Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

pasireotide

EU orphan designation number: EU/3/09/671   
Active ingredient: pasireotide
Indication: Treatment of Cushing's disease
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Signifor on 24/04/2012 with the number EU/1/12/753

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2009 Centralised Orphan - Designation EMEA/OD/052/09 (2009)7856 of 08/10/2009